Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

18 May 2007 16:41

Cubus Lux plc18 May 2007 For immediate release 18 May 2007 CUBUS LUX PLC "Cubus Lux" or "the Company" Board Appointments Cubus Lux, the Croatian leisure and tourism company, announces the appointmentsof Stephen McCann and Francisco Alvarez to its board of directors ("Board"). Stephen McCann has served as Chief Financial Officer of the Company sincejoining in March 2006. From 1991 Stephen was with Viktor Achter Ltd a UKautomotive trim producer, as finance director and company secretary. Followingthe acquisition of Viktor Achter Ltd by Milliken & Co, a private US Textilecompany, he relocated to Germany to become finance director of the enlargedgroup. He joined Viktor Achter Ltd from British Vita Plc, a polymers company inthe chemicals sector, where from 1986 to 1991 he was a senior manager coveringthe roles of international accountant and financial controller and later becameassistant group treasurer. Stephen John McCann, aged 47, was appointed as director of the Company on 8March 2007 and is currently a director of Crvena Ru?a d.o.o., Quibus Ltd, Quibusd.o.o., Cubus Lux Gradenje d.o.o., Cubus Lux Projektiranje d.o.o., Cubus LuxTenis d.o.o., Cubus Lux Usluge d.o.o.. Stephen McCann currently holds 300,000ordinary shares in the Company and has share options over a further 300,000ordinary shares in the Company. Francisco Alvarez joins the Board as a non-executive Director and brings withhim significant experience in financial markets, having held the position ofchief financial officer of the Valencia Stock Exchange from 1995 until 2000.Prior to that, he worked for the Paris Bourse Stock Exchange for 23 years. Asvice president between 1992 and 1995, he was responsible for the internationalrelationships of the Paris Bourse having previously headed the team whichdesigned and implemented the current trading platform NSC which has beenadopted by Euronext. Most recently, in 2003 Francisco set up ?TICA SolucionesFinancieras, an independent company offering financial services to entrepreneursand individual investors, after a spell as deputy manager of Banco Inversionwhich he joined in December 2003 to develop the bank's strategy in Spainfollowing its acquisition by the HVB Group. In addition, Francisco is the author of 3 economics books, has a PhD inelectronics applied to finance (Paris Sorbonne University), an MBA from theINSEAD (Fontainebleau) and has received the following accolades: • 1997 - president of the Fundacion de Estudios Bursatiles y Financieros • 1998 - President of the European Association of Financial Centres • 2000 - he was designated as "the economic man of the year" within the Valencia region by the regional government • 2001 - nominated "Chevalier de l'Ordre du Merit Civil" by the French government for the activities developed to promote the French economical aspects around the world. Francisco Alvarez-Molina, aged 60, was appointed as director of the Company on 8March 2007 and is currently a director of Etica Soluciones Financieras SA,Gesfesa SA, Hispanet SA, Openfinance SL, Coltec SL and Allveritas InversionesSL. Additional Information Save as set out above, there are no other disclosures in respect of StephenMcCann and Francisco Alvarez that fall to be made under Rule 17 or paragraph (g)of Schedule 2 to the AIM Rules for Companies. For further information please contact: Cubus Lux Plc Christian Kaiser, Director +44 7767 766 243 Threadneedle Communications Graham Herring/Josh Royston 020 7936 9605 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSDirectorate change
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20222:05 pmRNSSecond Price Monitoring Extn
14th Mar 20222:00 pmRNSPrice Monitoring Extension
14th Mar 20227:00 amRNSLaunch of outdoor marketing campaign
8th Mar 202211:03 amRNSShare purchase by CEO
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20227:00 amRNSExercise of Warrants
1st Mar 20227:00 amRNSLaunch of Rejuvenating Cannabinoid Face Serum
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20222:06 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:01 pmRNSPrice Monitoring Extension
21st Feb 202211:05 amRNSSecond Price Monitoring Extn
21st Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20229:05 amRNSSecond Price Monitoring Extn
21st Feb 20229:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSStrategy and trading update
2nd Feb 20227:00 amRNSWhite paper on cannabinoids and skin aging
7th Jan 20221:00 pmRNSResults of Annual General Meeting
15th Dec 20217:00 amRNSAnnual General Meeting update
8th Dec 20217:00 amRNSGrant of Options to CEO
6th Dec 20211:57 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSAppointment of new CEO
3rd Dec 20217:00 amRNSAnnual results
1st Dec 20217:00 amRNSLaunch of inaugural products & ecommerce platform
11th Nov 20217:00 amRNSAdvertising and PR agencies appointed
8th Nov 20212:05 pmRNSSecond Price Monitoring Extn
8th Nov 20212:00 pmRNSPrice Monitoring Extension
8th Nov 202111:05 amRNSSecond Price Monitoring Extn
8th Nov 202111:00 amRNSPrice Monitoring Extension
1st Nov 20217:00 amRNSGrant of Share Options and update on warrants
4th Oct 20219:06 amRNSSecond Price Monitoring Extn
4th Oct 20219:00 amRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSDirector dealings & TR1 notification
16th Aug 20217:00 amRNSSupply agreement signed with Chanelle McCoy Health
2nd Aug 20217:00 amRNSShare disposal by significant shareholder
28th Jul 20212:06 pmRNSSecond Price Monitoring Extn
28th Jul 20212:00 pmRNSPrice Monitoring Extension
10th Jun 20217:00 amRNSSupply agreement signed with Willow Biosciences
25th May 20217:00 amRNSCellular Goods Interim Results
6th May 20217:00 amRNSGrant of Warrants and Extension of Exercise Period
20th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSCellular Goods boosts team with five appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.